Measurement of urinary kallikrein acitvity by kinin radioimmunoassay.
We have established a simplified assay system for the measurement of urinary kallikrein activity by utilizing the sensitive and specific radioimmunoassay system of kinins previously reported from our laboratory. Kinins were generated by incubating urine samples (50 microliter) with kininogen (1500 ng) in the presence of kininase inhibitors, and the generated kinins were measured by radioimmunoassay. Since the cross reactivity of kininogen in the kinin radioimmunoassay system was not recognized at dose up to 1.0 microgram, the amount of untreated kininogen in the radioimmunoassay samples did not interfere with the measurement of kinins. This eliminated the necessity for a kininogen extraction procedure. A good linear correlation (r = 0.939, p less than 0.001) was observed between the urinary kallikrein activity determined by this assay system (kininogenase activity) and that by esterolytic acitvity. Urinary kallikrein activity was 3.3 +/- 0.9 microgram/min/24 hour urine (mean +/- SEM), 1.4 +/- 0.4 microgram/min/24 hour urine and 0.25 +/- 0.06 microgram/min/24 hour urine in 6 normal subjects, 7 patients with non-complicated essential hypertension and 4 patients with chronic renal failure, respectively. Thus, urinary kallikrein activity was significantly lower in the patients with essential hypertension (p less than 0.05) and the patients with chronic renal failure (p less than 0.01) than in the normal subjects.
D001920:Bradykinin; D004492:Edetic Acid; D005069:Evaluation Studies as Topic; D006801:Humans; D006973:Hypertension / Q000652:urine; D007610:Kallikreins / Q000652:urine*; D007676:Kidney Failure, Chronic / Q000652:urine; D007704:Kininogens; D007705:Kinins / Q000652:urine*; D010618:Phenanthrolines; D011863:Radioimmunoassay / Q000379:methods*; D013223:Statistics as Topic
D007704:Kininogens; D007705:Kinins; D010618:Phenanthrolines; D004492:Edetic Acid; D007610:Kallikreins; D001920:Bradykinin